Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR1 | P30872 | 4/20 | 0.49 |
| ▸ | SSTR2 | P30874 | 4/20 | 0.49 |
| ▸ | SSTR4 | P31391 | 4/20 | 0.49 |
| ▸ | SSTR3 | P32745 | 4/20 | 0.49 |
| ▸ | SSTR5 | P35346 | 4/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.46 |
| ▸ | TACR1 | P25103 | 4/20 | 0.46 |
| ▸ | CDC25B | P30305 | 5/20 | 0.44 |
| ▸ | GJB2 | P29033 | 2/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.43 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.43 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3233658 | 1.00 | SSTR1 (0.49) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL3233638 | 1.00 | SSTR1 (0.49) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL3240746 | 0.99 | SSTR1 (0.50) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL5909798 | 0.99 | SSTR1 (0.50) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL7572141 | 0.93 | SSTR1 (0.49) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL7568699 | 0.93 | SSTR2 (0.49) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL7572138 | 0.93 | SSTR1 (0.49) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL7568703 | 0.92 | SSTR1 (0.52) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL7572033 | 0.92 | SSTR1 (0.47) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL7565812 | 0.91 | SSTR1 (0.58) | SSTR1SSTR2SSTR4SSTR3SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1232167-B1 | SYNTHETIC OLIGOMANNOSIDES, PREPARATION AND USES THEREOF | CT HOSPITALIER REGIONAL ET UNI (FR) | 2010-05-05 | — | — | EP | disclosed |
| US-20060270627-A1 | Synthetic oligomannosides, preparation and uses thereof | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE (CHRU) (FR) | 2006-11-30 | — | — | US | disclosed |
| US-7109182-B2 | Synthetic oligomannosides, preparation and uses thereof | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE (CHRU) (FR) | 2006-09-19 | — | — | US | disclosed |
| US-20030105060-A1 | Synthetic oligomannosides, preparation and uses thereof | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE (CHRU) (FR) | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105060-A1 | Synthetic oligomannosides, preparation and uses thereof | DDOST, MANBA, ALG1 | SSTR1 3756/4885SSTR2 3837/4885SSTR4 2898/4885 |
| US-20060270627-A1 | Synthetic oligomannosides, preparation and uses thereof | DDOST, MANBA, ALG1 | SSTR1 3756/4885SSTR2 3837/4885SSTR4 2898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.